Himes Ryan W, Barlow Sarah E, Bove Kevin, Quintanilla Norma M, Sheridan Rachel, Kohli Rohit
Section of Gastroenterology and Hepatology, Department of Pediatrics and
Section of Gastroenterology and Hepatology, Department of Pediatrics and.
Pediatrics. 2016 Oct;138(4). doi: 10.1542/peds.2016-0214. Epub 2016 Sep 13.
Lysosomal acid lipase deficiency (LAL-D) is a classic lysosomal storage disorder characterized by accumulation of cholesteryl ester and triglyceride. Although it is associated with progressive liver injury, fibrosis, and end-stage liver disease in children and adolescents, LAL-D frequently presents with nonspecific signs that overlap substantially with other, more common, chronic conditions like nonalcoholic fatty liver disease (NAFLD), metabolic syndrome, and certain inherited dyslipidemias. We present 2 children with NAFLD who achieved clinically significant weight reduction through healthy eating and exercise, but who failed to have the anticipated improvements in aminotransferases and γ-glutamyl transferase. Liver biopsies performed for these "treatment failures" demonstrated significant microvesicular steatosis, prompting consideration of coexisting metabolic diseases. In both patients, lysosomal acid lipase activity was low and LIPA gene testing confirmed LAL-D. We propose that LAL-D should be considered in the differential diagnosis when liver indices in patients with NAFLD fail to improve in the face of appropriate body weight reduction.
溶酶体酸性脂肪酶缺乏症(LAL-D)是一种典型的溶酶体贮积病,其特征为胆固醇酯和甘油三酯蓄积。尽管它与儿童和青少年的进行性肝损伤、肝纤维化及终末期肝病相关,但LAL-D常表现出非特异性体征,这些体征与其他更常见的慢性疾病如非酒精性脂肪性肝病(NAFLD)、代谢综合征及某些遗传性血脂异常有很大重叠。我们报告了2例患有NAFLD的儿童,他们通过健康饮食和运动实现了临床上显著的体重减轻,但转氨酶和γ-谷氨酰转移酶却未出现预期改善。对这些“治疗失败”病例进行的肝活检显示有明显的微泡性脂肪变,这促使考虑并存的代谢性疾病。在这2例患者中,溶酶体酸性脂肪酶活性均较低,LIPA基因检测确诊为LAL-D。我们建议,当NAFLD患者在适当减轻体重后肝脏指标仍未改善时,在鉴别诊断中应考虑LAL-D。